Report Detail

Pharma & Healthcare Global Liver Cirrhosis Market Insights, Forecast to 2025

  • RnM2816701
  • |
  • 16 May, 2019
  • |
  • Global
  • |
  • 118 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Liver Cirrhosis Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Liver Cirrhosis Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Liver Cirrhosis Market Size Growth Rate by Product
      • 1.4.2 Alcoholic Cirrhosis
      • 1.4.3 Atrophic Cirrhosis
      • 1.4.4 Biliary Cirrhosis
      • 1.4.5 Cardiac Cirrhosis
      • 1.4.6 Cryptogenic Cirrhosis
    • 1.5 Market by End User
      • 1.5.1 Global Liver Cirrhosis Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Specialty Clinics
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Liver Cirrhosis Market Size
      • 2.1.1 Global Liver Cirrhosis Revenue 2014-2025
      • 2.1.2 Global Liver Cirrhosis Sales 2014-2025
    • 2.2 Liver Cirrhosis Growth Rate by Regions
      • 2.2.1 Global Liver Cirrhosis Sales by Regions
      • 2.2.2 Global Liver Cirrhosis Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Liver Cirrhosis Sales by Manufacturers
      • 3.1.1 Liver Cirrhosis Sales by Manufacturers
      • 3.1.2 Liver Cirrhosis Sales Market Share by Manufacturers
      • 3.1.3 Global Liver Cirrhosis Market Concentration Ratio (CR5 and HHI)
    • 3.2 Liver Cirrhosis Revenue by Manufacturers
      • 3.2.1 Liver Cirrhosis Revenue by Manufacturers (2014-2019)
      • 3.2.2 Liver Cirrhosis Revenue Share by Manufacturers (2014-2019)
    • 3.3 Liver Cirrhosis Price by Manufacturers
    • 3.4 Liver Cirrhosis Manufacturing Base Distribution, Product Types
      • 3.4.1 Liver Cirrhosis Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Liver Cirrhosis Product Type
      • 3.4.3 Date of International Manufacturers Enter into Liver Cirrhosis Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Liver Cirrhosis Sales by Product
    • 4.2 Global Liver Cirrhosis Revenue by Product
    • 4.3 Liver Cirrhosis Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Liver Cirrhosis Breakdown Data by End User

    6 North America

    • 6.1 North America Liver Cirrhosis by Countries
      • 6.1.1 North America Liver Cirrhosis Sales by Countries
      • 6.1.2 North America Liver Cirrhosis Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Liver Cirrhosis by Product
    • 6.3 North America Liver Cirrhosis by End User

    7 Europe

    • 7.1 Europe Liver Cirrhosis by Countries
      • 7.1.1 Europe Liver Cirrhosis Sales by Countries
      • 7.1.2 Europe Liver Cirrhosis Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Liver Cirrhosis by Product
    • 7.3 Europe Liver Cirrhosis by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Liver Cirrhosis by Countries
      • 8.1.1 Asia Pacific Liver Cirrhosis Sales by Countries
      • 8.1.2 Asia Pacific Liver Cirrhosis Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Liver Cirrhosis by Product
    • 8.3 Asia Pacific Liver Cirrhosis by End User

    9 Central & South America

    • 9.1 Central & South America Liver Cirrhosis by Countries
      • 9.1.1 Central & South America Liver Cirrhosis Sales by Countries
      • 9.1.2 Central & South America Liver Cirrhosis Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Liver Cirrhosis by Product
    • 9.3 Central & South America Liver Cirrhosis by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Liver Cirrhosis by Countries
      • 10.1.1 Middle East and Africa Liver Cirrhosis Sales by Countries
      • 10.1.2 Middle East and Africa Liver Cirrhosis Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Liver Cirrhosis by Product
    • 10.3 Middle East and Africa Liver Cirrhosis by End User

    11 Company Profiles

    • 11.1 F Hoffman La-Roche
      • 11.1.1 F Hoffman La-Roche Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 F Hoffman La-Roche Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 F Hoffman La-Roche Liver Cirrhosis Products Offered
      • 11.1.5 F Hoffman La-Roche Recent Development
    • 11.2 GlaxoSmithKline
      • 11.2.1 GlaxoSmithKline Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GlaxoSmithKline Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GlaxoSmithKline Liver Cirrhosis Products Offered
      • 11.2.5 GlaxoSmithKline Recent Development
    • 11.3 Gilead Sciences
      • 11.3.1 Gilead Sciences Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Gilead Sciences Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Gilead Sciences Liver Cirrhosis Products Offered
      • 11.3.5 Gilead Sciences Recent Development
    • 11.4 Johnson & Johnson
      • 11.4.1 Johnson & Johnson Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Johnson & Johnson Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Johnson & Johnson Liver Cirrhosis Products Offered
      • 11.4.5 Johnson & Johnson Recent Development
    • 11.5 Merck
      • 11.5.1 Merck Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Merck Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Merck Liver Cirrhosis Products Offered
      • 11.5.5 Merck Recent Development
    • 11.6 Bristol-Myers Squibb
      • 11.6.1 Bristol-Myers Squibb Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bristol-Myers Squibb Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bristol-Myers Squibb Liver Cirrhosis Products Offered
      • 11.6.5 Bristol-Myers Squibb Recent Development
    • 11.7 Conatus Pharmaceuticals
      • 11.7.1 Conatus Pharmaceuticals Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Conatus Pharmaceuticals Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Conatus Pharmaceuticals Liver Cirrhosis Products Offered
      • 11.7.5 Conatus Pharmaceuticals Recent Development
    • 11.8 Gwo Xi Stem Cell Applied Technology
      • 11.8.1 Gwo Xi Stem Cell Applied Technology Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Products Offered
      • 11.8.5 Gwo Xi Stem Cell Applied Technology Recent Development
    • 11.9 Instituto Grifols
      • 11.9.1 Instituto Grifols Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Instituto Grifols Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Instituto Grifols Liver Cirrhosis Products Offered
      • 11.9.5 Instituto Grifols Recent Development
    • 11.10 Intercept Pharmaceuticals
      • 11.10.1 Intercept Pharmaceuticals Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Intercept Pharmaceuticals Liver Cirrhosis Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Intercept Pharmaceuticals Liver Cirrhosis Products Offered
      • 11.10.5 Intercept Pharmaceuticals Recent Development

    12 Future Forecast

    • 12.1 Liver Cirrhosis Market Forecast by Regions
      • 12.1.1 Global Liver Cirrhosis Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Liver Cirrhosis Revenue Forecast by Regions 2019-2025
    • 12.2 Liver Cirrhosis Market Forecast by Product
      • 12.2.1 Global Liver Cirrhosis Sales Forecast by Product 2019-2025
      • 12.2.2 Global Liver Cirrhosis Revenue Forecast by Product 2019-2025
    • 12.3 Liver Cirrhosis Market Forecast by End User
    • 12.4 North America Liver Cirrhosis Forecast
    • 12.5 Europe Liver Cirrhosis Forecast
    • 12.6 Asia Pacific Liver Cirrhosis Forecast
    • 12.7 Central & South America Liver Cirrhosis Forecast
    • 12.8 Middle East and Africa Liver Cirrhosis Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Liver Cirrhosis Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and chronic alcohol abuse.
      Alcohol has been identified as the strongest risk factor for liver cirrhosis.
      The global Liver Cirrhosis market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Liver Cirrhosis market based on company, product type, end user and key regions.

      This report studies the global market size of Liver Cirrhosis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liver Cirrhosis in these regions.
      This research report categorizes the global Liver Cirrhosis market by top players/brands, region, type and end user. This report also studies the global Liver Cirrhosis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      F Hoffman La-Roche
      GlaxoSmithKline
      Gilead Sciences
      Johnson & Johnson
      Merck
      Bristol-Myers Squibb
      Conatus Pharmaceuticals
      Gwo Xi Stem Cell Applied Technology
      Instituto Grifols
      Intercept Pharmaceuticals

      Market size by Product
      Alcoholic Cirrhosis
      Atrophic Cirrhosis
      Biliary Cirrhosis
      Cardiac Cirrhosis
      Cryptogenic Cirrhosis
      Market size by End User
      Hospitals
      Specialty Clinics

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Liver Cirrhosis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Liver Cirrhosis market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Liver Cirrhosis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Liver Cirrhosis submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Liver Cirrhosis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liver Cirrhosis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Liver Cirrhosis . Industry analysis & Market Report on Liver Cirrhosis is a syndicated market report, published as Global Liver Cirrhosis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Liver Cirrhosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,125.01
      4,687.52
      6,250.02
      3,471.71
      5,207.56
      6,943.42
      420,365.40
      630,548.10
      840,730.80
      268,573.11
      402,859.67
      537,146.22
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report